EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma

References

• ChenWZhengRZengHZhangSHeJAnnual report on status of cancer in China, 2011Chin J Cancer Res201527121225717220
   PubMed Web of Science ®Google Scholar
• WHOCancer fact sheet No. 297 Reviewed120132012
   Google Scholar
• FialaOPesekMFinekJBenesovaLBortlicekZMinarikMGene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR–TKI treatment efficacyAnticancer Res20133341705171123564819
   PubMed Web of Science ®Google Scholar
• WuKHuangRSHouseLChoWCNext-generation sequencing for lung cancerFuture Oncol2013991323133623980680
   PubMed Web of Science ®Google Scholar
• TetsuOHangauerMJPhuchareonJEiseleDWMcCormickFDrug resistance to EGFR inhibitors in lung cancerChemotherapy201661S522323526910730
   PubMedGoogle Scholar
• GenovaCHirschFRClinical potential of necitumumab in non-small cell lung carcinomaOnco Targets Ther201695427543727621656
   PubMed Web of Science ®Google Scholar
• SongZZhangYEfficacy of gefitinib or erlotinib in patients with squamous cell lung cancerArch Med Sci201511116416825861304
   PubMedGoogle Scholar
• TanWLNgQSThe continuing role of epidermal growth factor receptor tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lungTransl Lung Cancer Res20165110610926958503
   PubMed Web of Science ®Google Scholar
• GazdarAFActivating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitorsOncogene200928 Suppl 1S24S3119680293
   PubMedGoogle Scholar
• SomasundaramASocinskiMABurnsTFPersonalized treatment of EGFR mutant and ALK-positive patients in NSCLCExpert Opinion Pharmacother2014151826932708
   PubMed Web of Science ®Google Scholar
• LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med2004350212129213915118073
   PubMed Web of Science ®Google Scholar
• LeeVHTinVPChoyTSAssociation of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancerJ Thorac Oncol2013891148115523945384
   PubMed Web of Science ®Google Scholar
• MidhaADeardenSMcCormackREGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII)Am J Cancer Res201559289226609494
   PubMed Web of Science ®Google Scholar
• FangWZhangJLiangWEfficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for Chinese patients with squamous cell carcinoma of lung harboring EGFR mutationJ Thorac Dis20135558559224255770
   PubMedGoogle Scholar
• RossiEDGerhardRCirnesLMachadoJCSchmittFDetection of common and less frequent EGFR mutations in cytological samples of lung cancerActa Cytol201458327528024924582
   PubMedGoogle Scholar
• ChiuCHChouTYChiangCLTsaiCMShould EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?Cancer Chemother Pharmacol201474466166525053390
   PubMedGoogle Scholar
• XuJChuTJinBEpidermal growth factor receptor tyrosine kinase inhibitors in advanced squamous cell lung cancerClin Lung Cancer201617430931426725853
   PubMedGoogle Scholar
• MuXLLiLYZhangXTGefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non-small cell lung cancerClin Cancer Res200511124289429415958609
   PubMed Web of Science ®Google Scholar
• XuJZhangYJinBEfficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in ChinaJ Cancer Res Clin Oncol201614261325133026942444
   PubMed Web of Science ®Google Scholar
• HataAKatakamiNYoshiokaHHow sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations?J Thorac Oncol201381899523242440
   PubMedGoogle Scholar
• ParkSHHaSYLeeJIEpidermal growth factor receptor mutations and the clinical outcome in male smokers with squamous cell carcinoma of lungJ Korean Med Sci200924344845219543508
   PubMedGoogle Scholar
• KruglyakKMLinEOngFSNext-generation sequencing and applications to the diagnosis and treatment of lung cancerAdv Exp Med Biol201689012313626703802
   PubMed Web of Science ®Google Scholar
• de BiaseDVisaniMMalapelleUNext-generation sequencing of lung cancer EGFR exons 18–21 allows effective molecular diagnosis of small routine samples (cytology and biopsy)PloS One2013812e8360724376723
   PubMed Web of Science ®Google Scholar
• ShahiRBDe BrakeleerSDe GreveJGeersCIn’t VeldPTeugelsEDetection of EGFR–TK domain-activating mutations in NSCLC with generic PCR-based methodsAppl Immunohistochem Mol Morphol201523316317125751592
   PubMedGoogle Scholar
• LuthraRChenHRoy-ChowdhuriSSinghRRNext-generation sequencing in clinical molecular diagnostics of cancer: advantages and challengesCancers2015742023203626473927
   PubMed Web of Science ®Google Scholar
• ShaoDLinYLiuJA targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinomaSci Rep201662233826936516
   PubMed Web of Science ®Google Scholar
• GrayPNDunlopCLElliottAMNot all next generation sequencing diagnostics are created equal: understanding the nuances of solid tumor assay design for somatic mutation detectionCancers2015731313133226193321
   PubMedGoogle Scholar
• KhooCRogersT-MFellowesABellAFoxSMolecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyondTransl Lung Cancer Res20154212625870795
   PubMed Web of Science ®Google Scholar
• SelvaggiGNovelloSTorriVEpidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancerAnn Oncol2004151283214679115
   PubMed Web of Science ®Google Scholar
• PallisAGVoutsinaAKalikakiA‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancerBr J Cancer200797111560156618000506
   PubMed Web of Science ®Google Scholar
• MiyamaeYShimizuKHiratoJSignificance of epidermal growth factor receptor gene mutations in squamous cell lung carcinomaOncol Rep201125492121318227
   PubMedGoogle Scholar
• BircanSBalogluHKucukodaciZBircanAEGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot studyMed Oncol20143188724973952
   PubMedGoogle Scholar
• AkbariMHansenMDHalgunsetJSkorpenFKrokanHELow copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent mannerJ Mol Diagn200571363915681472
   PubMedGoogle Scholar
• QinBMChenXZhuJDPeiDQIdentification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapyCell Res200515321221715780185
   PubMed Web of Science ®Google Scholar
• ZhangXChangASomatic mutations of the epidermal growth factor receptor and non-small-cell lung cancerJ Med Genet200744316617217158592
   PubMedGoogle Scholar
• KanedaTHataATomiokaHPossible differential EGFR–TKI efficacy among exon 19 deletional locations in EGFR-mutant non-small cell lung cancerLung Cancer201486221321825304185
   PubMed Web of Science ®Google Scholar
• BircanSBalogluHKucukodaciZBircanAEGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot studyMed Oncol20143188724973952
   PubMedGoogle Scholar
• LavnerYKotlarDCodon bias as a factor in regulating expression via translation rate in the human genomeGene2005345112713815716084
   PubMedGoogle Scholar
• PlotkinJBKudlaGSynonymous but not the same: the causes and consequences of codon biasNat Rev Genet2011121324221102527
   PubMed Web of Science ®Google Scholar
• LampsonBLPershingNLPrinzJARare codons regulate KRas oncogenesisCurr Biol2013231707523246410
   PubMed Web of Science ®Google Scholar
• SupekFMinanaBValcarcelJGabaldonTLehnerBSynonymous mutations frequently act as driver mutations in human cancersCell201415661324133524630730
   PubMed Web of Science ®Google Scholar
• HenseWAndersonNHutterSStephanWParschJCarliniDBExperimentally increased codon bias in the Drosophila Adh gene leads to an increase in larval, but not adult, alcohol dehydrogenase activityGenetics2010184254755519966063
   PubMedGoogle Scholar